Peter Ciszewski, CheckRare

Rare Disease Discussions

News and clinical perspective including CME programs focused on rare diseases. CheckRare focuses on rare and neglected diseases.

Vizitează neapărat site-ul podcastului și susține-i creatorul: www.checkrare.com

Autor

Peter Ciszewski, CheckRare

Categorie

Health

Site-ul podcastului

www.checkrare.com

Cel mai nou episod

19 nov. 2026

Unde asculți?

Podcasturi în aplicație Replaio Radio În curând

Podcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor

Descarcă din Google Play Instalează gratuit Android 10 mil.+ descărcări · nota 4,7+ iOS în curând

Episoade

Ch 3: Mitigation Strategies to Address the Challenges in the Development of Gene Therapy Programs 22.12.2025

Alan Beggs, PhD Director of the Manton Center for Orphan Disease Research Sir Edwin and Lady Manton Professor of Pediatrics, Boston Children's Hospital Harvard Medical School, Boston, MA, USA The challenges that you've heard about are real. Some of them I think we could have foreseen others. There was no way to know until we actually started treating patients in clinic. But we now know that there...

Chapter 2: AAV Mediated Gene Therapies 22.12.2025

Alan Beggs, PhD Director of the Manton Center for Orphan Disease Research Sir Edwin and Lady Manton Professor of Pediatrics, Boston Children's Hospital Harvard Medical School, Boston, MA, USA   Julie A. Parsons, MD Haberfield Endowed Chair in Pediatric Neuromuscular Disorders Professor of Clinical Pediatrics and Neurology University of Colorado School of Medicine, Children's Hospital Colorado Auro...

Chapter 1: Introduction to Gene Directed Therapies 22.12.2025

Drs. Beggs and Parsons discuss the current status of gene therapies in rare neuromuscular disorders in this eight-part podcast series. This is derived from the symposium that was presented at the MDA 2025 conference in Dallas, Texas, in March 2025, and is intended for healthcare professionals only. This podcast includes information about investigational compounds that do not yet have a regulatory...

Chapter 8: Gene Therapy Discussion and Q&A 21.12.2025

Nicola Longo MD, PhD, and Mark Roberts, MD Drs. Longo and Roberts discussed the current status of gene therapies in rare neuromuscular disorders in this eight-part podcast series. This is derived from the symposium that was presented at World Symposium 2025 in San Diego, California on February 4th through 7th, 2025, and is intended for healthcare professionals only. This podcast includes informati...

Chapter 7: Ongoing Gene Therapies in Lysosomal Disorders 21.12.2025

Nicola Longo MD, PhD Professor and Vice Chair of Human Genetics, Allen and Charlotte Ginsburg Chair in Precision Genomic Medicine, Division of Clinical Genetics, Department of Human Genetics, University of California at Los Angeles (UCLA), Los Angeles, CA, USA Mark Roberts, MD Professor and Consultant Neurologist, University of Manchester, Manchester, UK Research Lead for Adult Metabolic Medicine...

Chapter 6: Gene Replacement Therapy in Lysosomal Disorders 21.12.2025

Nicola Longo MD, PhD Professor and Vice Chair of Human Genetics, Allen and Charlotte Ginsburg Chair in Precision Genomic Medicine, Division of Clinical Genetics, Department of Human Genetics, University of California at Los Angeles (UCLA), Los Angeles, CA, USA Mark Roberts, MD Professor and Consultant Neurologist, University of Manchester, Manchester, UK Research Lead for Adult Metabolic Medicine...

Chapter 5: Current Treatment Landscape and Limitations 21.12.2025

Nicola Longo MD, PhD, and Mark Roberts, MD Drs. Longo and Roberts discuss the current status of gene therapies in rare neuromuscular disorders in this eight-part podcast series. This is derived from the symposium that was presented at WORLDSymposium 2025 in San Diego, California on February 4th-7th 2025 and is intended for healthcare professionals only. This podcast includes information about inve...

Chapter 4: Lessons Learnt from Gene Therapy Trials 21.12.2025

Nicola Longo MD, PhD, and Mark Roberts, MD Nicola Longo MD, PhD Professor and Vice Chair of Human Genetics, Allen and Charlotte Ginsburg Chair in Precision Genomic Medicine, Division of Clinical Genetics, Department of Human Genetics, University of California at Los Angeles (UCLA), Los Angeles, CA, USA Mark Roberts, MD Professor and Consultant Neurologist, University of Manchester, Manchester, UK...

Chapter 3: Immune Responses and Other Safety Concerns Related to Gene Therapies 21.12.2025

Nicola Longo MD, PhD, and Mark Roberts, MD Nicola Longo MD, PhD Professor and Vice Chair of Human Genetics, Allen and Charlotte Ginsburg Chair in Precision Genomic Medicine, Division of Clinical Genetics, Department of Human Genetics, University of California at Los Angeles (UCLA), Los Angeles, CA, USA Mark Roberts, MD Profesor and Consultant Neurologist, University of Manchester, Manchester, UK R...

Chapter 2: Vectors, Different Strategies, Modes of Administration, and Targets 21.12.2025

Nicola Longo MD, PhD, and Mark Roberts, MD  Nicola Longo MD, PhD Professor and Vice Chair of Human Genetics, Allen and Charlotte Ginsburg Chair in Precision Genomic Medicine, Division of Clinical Genetics, Department of Human Genetics, University of California at Los Angeles (UCLA), Los Angeles, CA, USA Mark Roberts, MD Profesor and Consultant Neurologist, University of Manchester, Manchester, UK...

Chapter 1: Lysosomal Disorders and the Potential for Gene Therapies 17.12.2025

Nicola Longo MD, PhD Professor and Vice Chair of Human Genetics, Allen and Charlotte Ginsburg Chair in Precision Genomic Medicine, Division of Clinical Genetics, Department of Human Genetics, University of California at Los Angeles (UCLA), Los Angeles, CA, USA Mark Roberts, MD Professor and Consultant Neurologist, University of Manchester, Manchester, UK Research Lead for Adult Metabolic Medicine...

Catching the Clues, Changing the Course of Lysosomal Storage Disorders 10.12.2025

Chair Professor Yoshikatsu Eto Advanced Clinical Research Center, Southern Tohoku Research Center for Neuroscience, Tokyo, Japan Speakers Dr Nicole Muschol  International Center for Lysosomal Disorders (ICLD), University Medical Center, Hamburg-Eppendorf, Germany Professor Patrício Aguiar Inborn Errors of Metabolism Reference Center, Unidade Local de Saúde de Santa Maria / Faculty of Medicine, Lis...

Consider Rare: Suspecting and Diagnosing CIDP 15.11.2025

This accredited continuing education program is supported by an educational grant from Sanofi. Credit for the program can be obtained by visiting https://checkrare.com/learning/p-consider-rare-suspecting-and-diagnosing-cidp / .  This program, led by Jeffrey Allen, MD, Professor of Neurology at the University of Minnesota provides an overview on the diagnostic delays that often occur in patients wi...

Lysosomal Disorders and the Brain 14.10.2025

Ozlem Goker-Alpan, MD, Founder and President, Lysosomal & Rare Disorders Research & Treatment Center (LDRTC) and Raphael Schiffmann, MD, of the Texas Christian University, discuss best practices to identify and treat neurologic problems associated with lysosomal disorders. This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research...

Case Studies in Diagnosing and Managing FOP 01.10.2025

This program, led by Christiaan Scott, MD, Professor of Pediatric Rheumatology at the University of Ottawa and Raphaella Stander, MBCHB, Pediatrician at Atlantic Children’s Practice, focused  on three case studies to provide physicians with education on best practices to: 1) suspect and diagnose FOP, 2) monitor and manage younger children with FOP, and 3) monitor and manage older children and adul...

Immune Thrombocytopenia (ITP) Research Highlights: ISTH 2025 15.09.2025

This accredited CME program highlights the latest clinical research about immune thrombocytopenia (ITP), a rare thrombotic disorder.   Led by Shruti Chaturvedi, MD, this program provides a summary of clinically relevant data presented at the International Society of Thrombosis and Haemostatis Congress (ISTH 2025) that can enhance the care of patients with ITP.  This program is supported by an educ...

Immune Thrombotic Thrombocytopenic Purpura (iTTP) Research Highlights: ISTH 2025 15.09.2025

The accredited CME program highlights the latest clinical research about iTTP, a rare thrombotic disorder.   Led by Shruti Chaturvedi, MD, this activity provides a summary of clinically relevant data presented at the International Society of Thrombosis and Haemostatis Congress (ISTH 2025) that can enhance the care of patients with iTTP.  This program is supported by an educational grant from Sanof...

Hemophilia Research Highlights: ISTH 2025 15.09.2025

The accredited CME program highlights the latest clinical research about hemophilia, a rare, genetic bleeding disorder.   Led by Dr. Steven Pipe, MD, this activity provides a summary of clinically relevant data presented at the International Society of Thrombosis and Haemostatis Congress (ISTH 2025) that can enhance the care of patients with hemophilia.  This program is supported by an educational...

Myasthenia Gravis Clinical Research Highlights: AAN 2025 29.08.2025

This program is supported by an educational grant from UCB, Inc.  This accredited CME program highlights the latest clinical research about myasthenia gravis, a rare, autoimmune disease that targets the neuromuscular junction.  This program, led by Dr. James Howard Jr, provides a summary of clinically relevant data presented at the American Academy of Neurology Annual Meeting (AAN 2025) held in Sa...

Mastocytosis Control Test: Implications for Physicians 18.08.2025

Warner Carr, MD, Allergist and Immunologist at the Allergy and Asthma Associates of Southern California, discusses the mastocytosis control test and its implications for physicians.

Skeletal Involvement in Lysosomal Disorders 18.06.2025

Ozlem Goker-Alpan, MD, Founder and President, Lysosomal & Rare Disorders Research & Treatment Center (LDRTC) and Ravi Kamath, MD, PhD, of Fairfax Radiological Consultants & Inova Health System and University of Virginia School of Medicine Fairfax, Virginia, USA discuss best practices to identify and treat bone problems associated with lysosomal disorders. This continuing education acti...

Fabry Disease Research Highlights 26.05.2025

This program is supported by educational grants from Amicus Therapeutics, Inc. and Chiesi USA Inc. Fabry disease is an inherited lysosomal storage disease caused by mutations in the GLA gene, disrupting the function of the enzyme, α-galactosidase. This results in the accumulation of globotriaosylceramide (GL-3) and its deacylated form, globotriaosylsphingosine (lyso-GL-3), leading to progressive d...

Consider Rare: Suspecting and Diagnosing Fibrodysplasia Ossificans Progressiva (FOP) 05.05.2025

Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare genetic disorder characterized by abnormal bone development. Most babies with FOP appear normal and healthy at birth with one exception—the appearance of deformed big toes. Unfortunately, this common deformity can be attributed to other causes. This can result in a delay of years before a person is diagnosed with FOP properly. This educa...

Progressive Familial Intrahepatic Cholestasis (PFIC): Diagnosing, Treating, Monitoring 05.05.2025

This educational program, hosted by Patrick McKiernan, MD, Pediatric Hepatologist at Birmingham Children's Hospital NHS Foundation Trust and Nadia Ovchinsky, MD, Professor of Medicine at NYU Grossman School of Medicine discuss the recently published guidance on best practices to diagnose, treat, and monitor patients with PFIC. It also explains why the new guidance recommends the early use of IBAT...

Transforming Clinical Outcomes With Early Treatment of Lysosomal Disorders 04.04.2025

This CME program provides information on best practices to manage children with lysosomal disorders who have been identified by newborn screening. WIth the wide range of symptoms and severities that present for these rare conditions, it is not always certain when the best time to start treatment is in these patients. Continuing Education Information This continuing education activity is provided b...

Ascultă podcastul Rare Disease Discussions în Replaio

Radio și podcasturi într-o singură aplicație - gratuit și fără înregistrare. Instaleaz-o azi și nu rata lansarea

Descarcă din Google Play

Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice